Arrowhead Pharmaceuticals, Inc.

28.95 USD
-0.03 (-0.10%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Arrowhead Pharmaceuticals, Inc. stock is up 17.73% since 30 days ago. The next earnings date is Feb 5, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 45.83% of the previous 23 November’s closed higher than October. In the last 4 Unusual Options Trades, there were 3 CALLs, 1 PUT.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
19 Oct 14:01 19 Jan, 2024 30.00 CALL 190 311
19 Oct 14:01 15 Mar, 2024 30.00 CALL 222 583
19 Oct 14:02 15 Mar, 2024 30.00 CALL 1778 583
31 Oct 14:38 19 Jan, 2024 35.00 PUT 25 124

About Arrowhead Pharmaceuticals, Inc.

Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the. treatment of liver diseases associated with alpha-1 antitrypsin deficiency. ARO is also involved in the development of JNJ-3989, a subcutaneously administered RNAi therapeutic candidate to treat chronic hepatitis B virus infection; Olpasiran to reduce the production of apolipoprotein A.